Trial intelligence / Profile preview

Simplified Algorithm for PONV Prevention in Cancer Patients

NCT04411069Phase 2Completed

Sponsor
Instituto do Câncer do Estado de São Paulo
Start
Feb 2019
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of droperidol in postoperative nausea and vomiting (PONV), sponsored by Instituto do Câncer do Estado de São Paulo. Started Feb 2019; status: completed.

02

Drugs

droperidol
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT04411069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04411069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call